Sun Pharmaceuticals will announce its Q2FY21 earnings on Tuesday. The numbers are expected to be flattish, revenues will be flat at Rs 8,189 crore, EBITDA is expected to go up by nearly 2 percent and profits are expected to go up by 5.6 percent. CNBC-TV18’s Sonal Bhutra has more details.
(Edited by : Bivekananda Biswas)
First Published: Nov 2, 2020 4:54 PM IST